3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
blinatumomab
5
pegaspargase
2
Methotrexate
2
Dexamethasone
2
Daunorubicin
2
Cytarabine
2
revumenib
1
prednylidene
1
nilotinib
1
merphos
1
fludarabine
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
azathiopurine
1
auricularum
1
asparaginase erwinia chrysanthemi recombinant
1
X-Rays
1
Vincristine
1
Stem Cell Transplantation
1
Spinal Puncture
1
Specimen Handling
1
Rituximab
1
Prednisone
1
Phantoms, Imaging
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Mitoxantrone
1
Midazolam
1
Mercaptopurine
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Nuclear Medicine Department, Hospital
×
Clear all
No trials found.